Reveal complete autoimmune therapeutic impact with high-sensitivity adaptive immune repertoire profiling

Rare, self-reactive B and T cell clones drive autoimmune diseases like Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Celiac Disease (CD), and Type 1 Diabetes (T1D), but often elude conventional adaptive immune repertoire profiling. Identifying these low-frequency clonotypes, along with their isotype usage and mutation patterns, is essential for advancing biomarker discovery and therapeutic development.

Our highly sensitive adaptive immune receptor repertoire (AIRR) profiling services deliver the deep coverage and isotype-level resolution needed to uncover clonal-level insights. With seven-chain profiling, single-cell paired chain resolution, and expert analytical support, we help autoimmune drug development teams discover biomarkers, understand mechanisms of action, and develop more precise, targeted therapies.

Streamline autoimmune therapeutic development with multi-chain adaptive immune receptor repertoire profiling

Gain key insights into the autoimmune disease state

Autoimmune diseases are the third most common cause of chronic illness in the US, yet their mechanisms remain incompletely understood. The clonotypes that drive pathology are often rare, transient, and below the detection threshold of standard cell-based assays — making them easy to miss and difficult to interpret without the right tools.

Read this case study to learn how immune repertoire profiling:

  • Enables the discovery of new autoimmunity biomarkers.
  • Sheds light on the underlying mechanisms contributing to autoimmune diseases like RA and SLE.
  • Provides diagnostic predictor variables for RA.
Thumbnail image of a case study cover page titled ‘Immune Repertoire Profiling to Assess Therapeutic Response in Autoimmune Disease,’ featuring stylized scientific graphics and branding from iRepertoire, indicating immune repertoire analysis in autoimmune therapy evaluation

Characterize and predict therapeutic response

Autoimmune diseases are complex, multi-factorial, and dynamic. With immune profiling, it is possible to precisely monitor changes in immune cell diversity over time and post-therapy to identify biomarkers, inform clinical study design, and predict therapeutic response.

Read this case study to discover how immune repertoire profiling:

  • Enables quantitative and highly reproducible analysis of the full diversity of BCR and TCR repertoires.
  • Provides information about RA and SLE patient response to immunosuppressant therapy.
  • Contributes insights that may enable personalized medicine interventions for autoimmune disease management.

See how adaptive immune repertoire profiling reveals autoimmune disease insights

Two distinct subpopulations of marginal zone B cells exhibit differential antibody-producing capacities and radioresistance

This article identifies and characterizes two distinct subpopulations of marginal zone (MZ) B cells in mice—CD80^high^ and CD80^low^—which differ in antibody-producing capacity, radioresistance, and autoreactivity, illuminating new dimensions of B cell biology and adaptive immunity.

iRepertoire’s customizable solutions were especially critical for deep molecular comparison from rare or complex sample types, supporting translational studies on immune differentiation and tolerance.

Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients

This article presents a multi-omics study that uncovers pathogenesis differences in skin lesion generation between systemic lupus erythematosus (SLE) and idiopathic discoid lupus erythematosus (IDLE), using immune repertoire sequencing to show distinct B cell and T cell clonal landscapes that support precision diagnosis and therapeutic approaches.

Immune repertoire profiling was critical for distinguishing clonal architecture and immune diversity in SLE versus IDLE, establishing direct relationships between molecular findings and pathogenetic mechanisms.

Molecular mimicry-driven autoimmunity in chronic rhinosinusitis with nasal polyps

This article demonstrates that molecular mimicry-driven autoimmunity plays an important role in chronic rhinosinusitis with nasal polyps (CRSwNP), using immunoglobulin repertoire sequencing to reveal dominant B cell clones targeting both self and microbial antigens in affected tissue.

The use of iRepertoire’s workflows supported efficient antigen discovery and detailed characterization of the humoral immune repertoire, setting the stage for translational investigation and biomarker development in airway autoimmunity.

Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

This article introduces immuneREF, a novel computational framework for multidimensional, reference-based comparison of adaptive immune receptor repertoires. The study reveals that blood-derived immune repertoires from healthy and diseased populations are much more similar than previously assumed—highlighting only subtle differences across autoimmune conditions and infections.

Immune repertoire analysis is pivotal for understanding the molecular and clonal landscape of B and T cell diversity, enabling discovery of subtle immune changes linked to health or disease.

Explore our services

Bulk Immune Repertoire Profiling

Discover RepSeq+, our sensitive, quantitative, and high-throughput assay that combines multiplex PCR with NGS to analyze any combination of all seven chains of the adaptive immune system in a single reaction.

Single Cell V(D)J Profiling

Explore iPair, the first commercialized technology for capturing physically paired full-length V(D)J sequences in TCRs or BCRs from FACS isolated single cells in the same reaction well.

Data Analysis

Leverage our built-for-purpose, advanced AIRR analysis tools that translate raw sequence data into actionable insights.

Ready to get started?

iRepertoire serves as a leader in the field of immune repertoire profiling. We invite you to consult with our team of scientists to discover how our services can accelerate your analysis of immune cell function and diversity.